Abstract
A novel human cell line was established from a primary botryoid rhabdomyosarcoma. Reverse transcription polymerase chain reaction investigations of this cell line, called RUCH-2, demonstrated expression of the regulatory factors PAX3, Myf3 and Myf5. After 3.5 months in culture, cells underwent a crisis after which Myf3 and Myf5 could no longer be detected, whereas PAX3 expression remained constant over the entire period. Karyotype analysis revealed breakpoints in regions similar to previously described alterations in primary rhabdomyosarcoma tumour samples. Interestingly, cells progressed to a metastatic phenotype, as observed by enhanced invasiveness in vitro and tumour growth in nude mice in vivo. On the molecular level, microarray analysis before and after progression identified extensive changes in the composition of the extracellular matrix. As expected, down-regulation of tissue inhibitors of metalloproteinases and up-regulation of matrix metalloproteinases were observed. Extensive down-regulation of several death receptors of the tumour necrosis factor family suggests that these cells might have an altered response to appropriate apoptotic stimuli. The RUCH-2 cell line represents a cellular model to study multistep tumorigenesis in human rhabdomyosarcoma, allowing molecular comparison of tumorigenic versus metastatic cancer cells. © 2000 Cancer Research Campaign
Similar content being viewed by others
Article PDF
Change history
16 November 2011
This paper was modified 12 months after initial publication to switch to Creative Commons licence terms, as noted at publication
References
Anand G, Shapiro DN, Dickman PS and Prochownik EV (1994) Rhabdomyosarcomas do not contain mutations in the DNA binding domains of myogenic transcription factors. J Clin Invest 93: 5–9
Andreasen PA, Kjoller L, Christensen L and Duffy MJ (1997) The urokinase-type plasminogen activator system in cancer metastasis: a review. Int J Cancer 72: 1–22
Apte SS, Fukai N, Beier DR and Olsen BR (1997) The matrix metalloproteinase-14 (MMP-14) gene is structurally distinct from other MMP genes and is co-expressed with the TIMP-2 gene during mouse embryogenesis. J Biol Chem 272: 25511–25517
Barr FG, Galili N, Holick J, Biegel JA, Rovera G and Emanuel BS (1993) Rearrangement of the PAX3 paired box gene in the paediatric solid tumour alveolar rhabdomyosarcoma. Nat Genet 3: 113–117
Barr FG, Nauta LE and Hollows JC (1998) Structural analysis of Pax3 genomic rearrangements in alveolar rhabdomyosarcoma. Cancer Genet Cytogenet 102: 32–39
Betts DR, Koesters R, Plüss H-J and Niggli FK (1997) Routine karyotyping in Wilms' tumor. Cancer Genet Cytogenet 96: 151–156
Clark J, Rocques PJ, Braun T, Bober E, Arnold HH, Fisher C, Fletcher C, Brown K, Gusterson BA, Carter L and Cooper CS (1991) Expression of members of the myf gene family in human rhabdomyosarcoma. Br J Cancer 64: 1039–1042
Davis RJ, D'Cruz CM, Lovell MA, Biegel JA and Barr FG (1994) Fusion of PAX7 to FKHR by the variant t(1;13)(p36;q14) translocation in alveolar rhabdomyosarcoma. Cancer Res 54: 2869–2872
Galili N, Davis RJ, Fredericks WJ, Mukhopadhyay S, Rauscher, III FJ, Emanuel BS, Rovera G and Barr FG (1993) Fusion of a fork head domain gene to PAX3 in the solid tumour alveolar rhabdomyosarcoma. Nat Genet 5: 230–235
Glinsky GV, Glinsky VV, Ivanova AB and Hueser CJ (1997) Apoptosis and metastasis: increased apoptosis resistance of metastatic cancer cells is associated with the profound deficiency of apoptosis execution mechanisms. Cancer Lett 115: 185–193
ISCN (1995). An International System for Human Cytogenetic Nomenclature, Mitelman F (ed). S Karger: Basel
Kullendorff CM, Donner M, Mertens F and Mandahl N (1998) Chromosomal aberrations in a consecutive series of childhood rhabdomyosarcoma. Med Pediatr Oncol 30: 156–159
Ludolph DC and Konieczny SF (1995) Transcription factor families: muscling in on the myogenic program. FASEB J 9: 1595–1604
McAllister RM, Melnyk J, Finkelstein JZ, Adams EC and Gardner MB (1969) Cultivation in vitro of cells derived from a human rhabdomyosarcoma. Cancer 24: 520–526
Nanni P, Schiaffino S, De Giovanni C, Nicoletti G, Prodi G, Del Re B, Eusebi V, Ceccarelli C, Saggin L and Lollini P-L (1986) RMZ: a new cell line from a human alveolar rhabdomyosarcoma. in vitro expression of embryonic myosin. Br J Cancer 54: 1009–1014
Newton WA, Gehan EA, Webber BL, Marsden HB, van Unnik AJM, Hamoudi AB, Tsokos MG, Shimada H, Harms D, Schmidt D, Ninfo V, Cavazzana AO, Gonzalez-Crussi F, Parham DM, Reiman HM, Asmar L, Beltangady MS, Sachs NE, Triche TJ and Maurer HM (1995) Classification of rhabdomyosarcomas and related sarcomas. Cancer 76: 1073–1085
Pappo AS (1995) Rhabdomyosarcoma and other soft tissue sarcomas of childhood. Curr Opin Oncol 7: 361–366
Schäfer BW, Czerny T, Bernasconi M, Genini M and Busslinger M (1994) Molecular cloning and characterization of a human PAX-7 cDNA expressed in normal and neoplastic myocytes. Nucleic Acids Res 22: 4574–4582
Scrable HJ, Witte DP, Lampkin BC and Cavenee WK (1987) Chromosomal localization of the human rhabdomyosarcoma locus by mitotic recombination mapping. Nature 329: 645–647
Shapiro DN, Sublett JE, Li B, Downing JR and Naeve CW (1993) Fusion of PAX3 to a member of the forkhead family of transcription factors in human alveolar rhabdomyosarcoma. Cancer Res 53: 5108–5112
Takaoka A, Adachi M, Okuda H, Sato S, Yawata A, Hinoda Y, Takayama S, Reed JC and Imai K (1997) Anti-cell death activity promotes pulmonary metastasis of melanoma cells. Oncogene 14: 2971–2977
Tonin PN, Scrable H, Shimada H and Cavenee WK (1991) Muscle-specific gene expression in rhabdomyosarcomas and stages of human fetal skeletal muscle development. Cancer Res 51: 5100–5106
Tran TA, Kallakury BV, Ambros RA and Ross JS (1998) Prognostic significance of tumor necrosis factors and their receptors in nonsmall cell lung carcinoma. Cancer 83: 276–282
van den Oord JJ, Paemen L, Opdenakker G and de Wolf-Peeters C (1997) Expression of gelatinase B and the extracellular matrix metalloproteinase inducer EMMPRIN in benign and malignant pigment cell lesions of the skin. Am J Pathol 151: 665–670
Wang-Wuu S, Soukup S, Ballard E, Gotwals B and Lampkin B (1988) Chromosomal analysis of sixteen human rhabdomyosarcomas. Cancer Res 48: 983–987
Weber-Hall S, Anderson J, McManus A, Abe S, Nojima T, Pinkerton R, Pritchard-Jones K and Shipley J (1996) Gains, losses and amplification of genomic material in rhabdomyosarcoma analyzed by comparative genomic hybridization. Cancer Res 56: 3220–3224
Whang-Peng J, Knutsen T, Theil K, Horowitz ME and Triche T (1992) Cytogenetic studies in subgroups of rhabdomyosarcoma. Genes Chromosomes Cancer 5: 299–310
Wyllie AH (1997) Apoptosis and carcinogenesis. Eur J Cell Biol 73: 189–197
Author information
Authors and Affiliations
Rights and permissions
From twelve months after its original publication, this work is licensed under the Creative Commons Attribution-NonCommercial-Share Alike 3.0 Unported License. To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/3.0/
About this article
Cite this article
Scholl, F., Betts, D., Niggli, F. et al. Molecular features of a human rhabdomyosarcoma cell line with spontaneous metastatic progression. Br J Cancer 82, 1239–1245 (2000). https://doi.org/10.1054/bjoc.1999.1069
Received:
Revised:
Accepted:
Published:
Issue date:
DOI: https://doi.org/10.1054/bjoc.1999.1069
Keywords
This article is cited by
-
TERT Immunohistochemistry Is a Poor Predictor of TERT Promoter Mutations and Gene Expression in Follicular Thyroid Carcinoma
Endocrine Pathology (2018)
-
Spontaneous transformation of human granulosa cell tumours into an aggressive phenotype: a metastasis model cell line
BMC Cancer (2008)
-
Identification of IGFBP-6 as an effector of the tumor suppressor activity of SEMA3B
Oncogene (2008)
-
Diagnostic and Prognostic Sarcoma Signatures
Molecular Diagnosis & Therapy (2008)
-
Transcript profiling of Wilms tumors reveals connections to kidney morphogenesis and expression patterns associated with anaplasia
Oncogene (2005)
